Stock Chart
CELU
Type: SELL wallstreet
Strike: $3
Premium: $0.30
Expiry: May 15, 2026
Target: $3
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About CELU - Celularity Inc. Class A Common Stock
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
Key Statistics
More CELU Analysis
This CELU stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track CELU's price movements with trendlines, gamma walls, and key support/resistance levels.